Amyloidosis is a condition in which amyloid or abnormal protein accumulates in tissue or organs like the brain. There are many forms of amyloidosis based on the type of protein and where the deposits form. Common forms of the condition include primary or systemic amyloidosis in which the protein deposits affect the whole body, and secondary amyloidosis, which is usually the result of a chronic inflammatory disease like rheumatoid arthritis. Some amyloid deposits in the brain are a hallmark of Alzheimer’s disease and dementia.
Detecting amyloidosis is important because symptoms may be mild or subtle, but the condition comes with serious risks. If seniors could receive a diagnosis in the early stages, it would better prepare them for decisions regarding health and North Broward home care they need. Cardiac amyloidosis, for example, can weaken heart muscles and disrupt blood flood while renal amyloidosis can interfere with the ability to filter toxins and waste from the blood.
According to the U.S. Office of Rare Diseases (ORD), there are less than 200,000 people in the United States with amyloidosis, but the Amyloidosis Foundation believes the numbers are underreported as amyloidosis is difficult to detect and diagnosis.
There is no blood test to detect amyloidosis and a biopsy is usually required, but scientists at Linköping University in Sweden have developed a unique molecular probe capable of detecting many types of amyloid deposits in tissue. The probe was able to correctly identify every sample of amyloidosis when compared to the standard clinical tests as well as some amyloid deposits that traditional diagnostic tools could not detect.
The researchers say that, given the probe’s sensitivity, it can be a perfect complement to existing diagnostic methods like the Congo red stain and it may one day be a replacement for current invasive methods.
This new method is revolutionary as it may be used to detect amyloidosis before symptoms develop for faster diagnosis and more effective treatment to potentially avoid serious side effects of the condition. The non-invasive molecular probe could be used to identify amyloid deposits in patients who don’t exhibit symptoms. Researchers hope the science can be applied to other diseases involving amyloids, including Alzheimer’s disease. This would prepare seniors with the disease for plans involving finances, medical help, and North Broward Alzheimer’s care.
Diseases like Alzheimer’s and dementia often require more extensive help during the later stages of the disease. Home Care Assistance provides compassionate Alzheimer’s and dementia home care North Broward seniors can trust to help with daily activities around the house and personal care needs throughout the various stages of the disease. We also supplement these services with our proprietary Cognitive Therapeutics Method to stimulate cognitive function, sharpen mental acuity, and delay the onset of dementia symptoms at no additional cost. Learn more about our services by contacting a knowledgeable Care Manager today at 954-906-5161 to schedule a complimentary consultation.